Hispanic Breast Cancer Survivors Share Their Perceptions About Endocrine Blocking Therapy Adherence

Breast cancer is the leading cause of cancer-related mortality among Hispanic women in the U.S., despite a lower incidence compared to non-Hispanic White women. Hispanic women often face unique socio-economic and cultural barriers that impact timely diagnosis, treatment, and survival outcomes. Hormone receptor-positive breast cancer is prevalent in this population, with endocrine blocking therapy (EBT) recommended as a standard treatment. However, Hispanic breast cancer survivors exhibit higher rates of EBT non-adherence, influenced by factors such as side effects, medication access, and patient-provider communication. This study investigates the perceptions of Hispanic breast cancer survivors on EBT use and identifies factors contributing to adherence challenges, aiming to address disparities and improve outcomes.